Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.60 |
| ▸ | CCKBR | P32239 | 3/20 | 0.59 |
| ▸ | ACE | P12821 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | ECE1 | P42892 | 7/20 | 0.55 |
| ▸ | CCKAR | P32238 | 1/20 | 0.55 |
| ▸ | CTSC | P53634 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17534383 | 1.00 | ERAP2 (0.60) | ERAP2CCKBRACEMEN1KMT2A | |
| SCHEMBL30052714 | 0.95 | ACE (0.64) | ERAP2ACEMEN1KMT2AECE1 | |
| SCHEMBL30051469 | 0.92 | ACE (0.61) | ERAP2ACEMEN1KMT2AECE1 | |
| SCHEMBL29536181 | 0.92 | ACE (0.69) | ERAP2ACEECE1 | |
| SCHEMBL30999639 | 0.91 | CCKBR (0.63) | ERAP2CCKBRMEN1KMT2ACCKAR | |
| SCHEMBL30999620 | 0.91 | CCKBR (0.63) | ERAP2CCKBRMEN1KMT2ACCKAR | |
| SCHEMBL29470182 | 0.90 | ACE (0.57) | ERAP2ACEMEN1KMT2AECE1 | |
| SCHEMBL30999552 | 0.89 | CTSC (0.61) | ERAP2CCKBRACEMEN1KMT2A | |
| SCHEMBL30999602 | 0.89 | CTSC (0.61) | ERAP2CCKBRACEMEN1KMT2A | |
| SCHEMBL30999520 | 0.89 | CCKBR (0.63) | ERAP2CCKBRMEN1KMT2ACCKAR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9399661-B2 | Tetrapeptide copper catalysts capable of oxidizing hydrocarbons at room temperature | UNIVERSITY OF THE WEST INDIES (TT) | 2016-07-26 | — | — | US | disclosed |
| US-9399661-B2 | Tetrapeptide copper catalysts capable of oxidizing hydrocarbons at room temperature | UNIVERSITY OF THE WEST INDIES (TT) | 2016-07-26 | — | — | US | disclosed |
| US-20160060292-A1 | Tetrapeptide Copper Catalysts Capable Of Oxidizing Hydrocarbons At Room Temperature | UNIVERSITY OF THE WEST INDIES (TT) | 2016-03-03 | — | — | US | disclosed |
| US-20160060292-A1 | Tetrapeptide Copper Catalysts Capable Of Oxidizing Hydrocarbons At Room Temperature | UNIVERSITY OF THE WEST INDIES (TT) | 2016-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160060292-A1 | Tetrapeptide Copper Catalysts Capable Of Oxidizing Hydrocarbons At Room Temperature | SOD1, SOD3, AOC1 | ERAP2 187/4885CCKBR 1751/4885ACE 918/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.